Status:
COMPLETED
Tailored Intervention for Melanoma Patient's Families
Lead Sponsor:
Fox Chase Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Melanoma
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of the investigators' study is to find the best way to provide information about sun protection and skin cancer detection. The investigators want to see which of two methods most improves ...
Detailed Description
Eligible patients will be contacted to find out whether they have any living first degree relatives that we may contact to discuss their participation in our study. Eligible first degree relatives (F...
Eligibility Criteria
Inclusion
- Inclusion Criteria - Patients (for referral of FDRs):
- Newly diagnosed with cutaneous malignant melanoma (CMM) within the past 2 years but more than 3 months prior to being approached
- Seen at FCCC, FCCC Network, Temple, MCC, or HUP patient clinics
- Greater than 18 years of age
- English speaking
- Able to give meaningful informed consent
- Does NOT have a first-degree relative with CMM
- Inclusion Criteria - FDR (First Degree Relative):
- Current age of at least 21 years
- One or more of the following additional risk factors; blonde or red hair; marked freckling on the upper back; history of 3 or more blistering sunburns prior to age 20; 3 or more years of an outdoor summer job as a teenager; Actinic keratosis
- Able to give informed consent
- English speaking
- Has residential phone service
- No personal history of CMM or non-melanoma skin cancer
- No personal history of dysplastic nevi
- Exclusion Criteria - FDR:
- 2 or more first degree relatives with CMM
- Has had a total cutaneous examination (TCE) in the past 3 years AND has done skin self-examination (SSE) more than once in the past year AND has a sun protection habits mean score greater than or equal to 4 (often). We are selecting a set participants who are NOT compliant with TCE and are inconsistent/minimal performers of SSE and sun protection practices.
Exclusion
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
553 Patients enrolled
Trial Details
Trial ID
NCT00816374
Start Date
August 1 2005
End Date
May 1 2011
Last Update
May 16 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States, 33612
2
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
3
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111-2497